C12 — Medical Treatment Visa (C12)

The Medical Treatment Visa (C12) in Kazakhstan was established as a specialized entry mechanism designed to facilitate cross-border access to the nation’s growing healthcare infrastructure. Created under the framework of the Law of the Republic of Kazakhstan "On Population Migration," this visa category serves as a formal bridge between international patients and the country’s medical institutions. Its existence addresses a critical gap in the standard immigration system, which previously forced individuals seeking specialized procedures or consultations to navigate complex business or tourist visa channels that were ill-suited for long-term clinical stays. By formalizing the process through a dedicated medical visa, the Kazakh government has streamlined the entry of foreign nationals who require consistent, supervised care, ensuring that the immigration framework remains responsive to the humanitarian and professional needs of the global medical tourism sector. This visa effectively separates clinical visitors from general travelers, providing a legal pathway that accounts for the specific logistical requirements of medical recovery and ongoing treatment.

The ideal applicant for the C12 visa is an individual—or their necessary accompanying caregiver—who has secured a formal invitation from a licensed medical institution within Kazakhstan for the purpose of diagnosis, surgery, rehabilitation, or specialized consultation. While the visa is broad in its medical scope, it is particularly sought after by patients traveling for high-quality, cost-effective procedures in fields such as cardiology, reproductive medicine, and orthopedic surgery, where Kazakhstan has seen significant investment. What makes this visa distinctive compared to standard tourist or business permits is its specific alignment with the duration of a treatment plan, allowing for stays of up to 180 days, which provides the stability necessary for complex recovery periods. A notable benefit of the C12 is its focus on the patient’s support system, as it explicitly permits the inclusion of accompanying persons, thereby alleviating the stress of navigating a foreign healthcare system alone. However, the visa is strictly limited by its requirement for institutional sponsorship; applicants cannot simply enter for general wellness or elective preventative care without a documented medical necessity and a confirmed appointment from a registered Kazakh facility. This requirement ensures that the visa is utilized exclusively for genuine clinical purposes, maintaining the integrity of the country’s healthcare immigration policy while offering a reliable, structured entry route for those in need of professional medical intervention.